X   

Real-Time Quote

Enter Company or MF
   

Glenmark Pharmaceuticals Ltd. - Research Center

532296  GLENMARK  Group (A) BSE data View Tips   Add to :  Portfolio  |  Watchlist  |  Game

(Rs crore)

Cash flow

 Mar ' 09Mar ' 08Mar ' 07Mar ' 06Mar ' 05
Profit before tax 246.07 431.19 170.82 85.30 86.94
Net cashflow-operating activity 94.06 246.67 -8.83 -25.49 10.11
Net cash used in investing activity -589.14 -15.70 -237.92 -239.08 -203.87
Netcash used in fin. activity 495.62 -231.18 168.98 244.45 296.27
Net inc/dec in cash and equivlnt 0.53 -0.21 -77.77 -20.12 102.51
Cash and equivalnt begin of year 11.16 11.39 89.16 109.28 6.77
Cash and equivalnt end of year 11.69 11.18 11.39 89.16 109.28